Cure Kids Ventures (CKV) is New Zealand’s predominant seed and early stage healthcare investment fund that invests in New Zealand’s emerging healthcare companies which can positively impact the health of children.

CKV is owned by Cure Kids Foundation, New Zealand’s largest private funder of child health research. Our deal flow comes from our deep links to Universities, research institutes and organisations resulting from more than 40 years of private research funding.

Since 2008, Cure Kids Ventures (CKV) has invested in a portfolio of companies with products and services covering medical devices, medications, diagnostics, health information and healthcare delivery systems.

As a predominant investor in New Zealand’s seed and early stage healthcare and biotech sector, CKV has established a reputation in the investment community as an informed and value added investor. In addition to investment funds, we provide investee companies with healthcare industry specific expertise and access to industry networks.

CKV has recently launched its 3rd fund – a continuation of its decade plus of investing in emerging healthcare companies.

Our wide connections to medical research institutes, universities and industry organisations facilitate and enhance deal flow for investments.

Our team has global experience in the biotech, healthcare and medical devices industry. We have a highly desired blend of skills in early stage company development, intellectual property commercialisation, global expansion, science, finance and mergers and acquisitions.

Cure Kids Ventures is a vital part of Cure Kids’ vision for a healthy childhood for everyone